Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 19, 2002

View Archived Issues

Viragen and U. of Miami collaborate on immune enhancing drug for cancer

Rheumatoid arthritis test receives FDA approval

Serono updates second quarter progress

Oxagen and Pfizer enter target validation collaboration

Enrollment initiated in phase III atamestane trial

British Biotech and GeneSoft enter antibiotics drug discovery collaboration

Columbia submits NDA for testosterone buccal bioadhesive product

New backup compound for AD presented at ACS

MSI-1436 prevents the homeostatic metabolic response induced by decreased feeding in rats

SAR on novel PDE5 inhibitors reported by Pfizer

New ECTA-based antibacterial compounds designed at NewBiotics

Interferon inducers described by Sumitomo and Japan Energy at ACS meeting

Antifungal agents with anti-CaNMT activity designed at Nippon Roche

New 5-HT reuptake inhibitors identified at Lilly

Roche claims novel OSLC inhibitors in recent patent

New GABA-A receptor modulators and their use as anesthetics, sedatives, etc.

New antibacterial compounds in early development at GSK

Antibacterial streptogramin derivatives designed at Aventis Pharma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...